Benzyl 4-bromo-1,2-dihydrospiro[indole-3,4'-piperidine]-1'-carboxylate, 95+%, 250mg

3-Amino-2-methoxy-phenol, 97%, 500mg

1-Butanone, 1-(10H-phenothiazin-10-yl)-2-(5H-1,2,4-triazino[5,6-b]indol-3-ylthio)-, 98%, 50mg

methyl 3-(cyclohexylamino)-2-methylpropanoate, 95.0%, 10g

Tantalum foil 99.9% 0.05 x 50 x 50 mm 1 pc

4-tert-Butylcyclohexanecarbonyl chloride, 250mg

4,4,5,5-Tetramethyl-2-(tetrahydro-2H-pyran-4-yl)-1,3,2-dioxaborolane, 95.0%, 10g

3-Methoxy-5-methylpyrazin-2-amine, 95.0%, 5g

(R)-4-(tert-Butyl)-2-(2-chloro-6-(diphenylphosphino)phenyl)-4,5-dihydrooxazole, 97%, 250mg

tert-Butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3,6,7-tetrahydro-1H-azepine-1-carboxylate, 98%, 100mg

Mandatory signs tested in practice, 100 mm, 1 piece

Analytical and precision balance Pioneer® series Models with internal adjustment, factory calibrated, 0.001 g, 320 g, PX323 (W)

5-Nitropyridin-3-amine hydrochloride, 97%, 1g